Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
about
P1343
Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent mannerDevelopment and characterization of 5 canine B-cell lymphoma cell linesAuthentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin LymphomaArginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivationThe role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro studyComparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cellsEvidence of an oncogenic gammaherpesvirus in domestic dogs.Comprehensive genomic characterization of five canine lymphoid tumor cell lines.Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphomaDelineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets.Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applicationsDevelopment of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential.The regulation of the expression of ABCG2 gene through mitogen-activated protein kinase pathways in canine lymphoid tumor cell lines.A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.The effects of oncolytic reovirus in canine lymphoma cell lines.Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis.DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.Composition of lymphocyte subpopulations in normal canine lymph nodes.CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignanciesMechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20.JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation.In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma.STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma.In vitro antineoplastic effects of auranofin in canine lymphoma cells.The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines
P2860
Q27027137-5F348A11-7B23-45B1-ABDE-F7A5A94EAA57Q28483767-F5DEAA7F-5EDF-4CE5-9A71-E0EDE16C6DFDQ33600546-D6B1ABD7-EC56-4F2B-89FD-ADCCD4D84A66Q34326749-E3C4451D-AD19-4D99-970D-62522212ECA8Q34534572-48D78E86-3B14-4384-95F6-73C2F2ECDA1AQ34568337-DD096143-3E7B-4D52-BD3D-7D06ABCE29A1Q34704521-F079F1AB-4C2F-4098-98E6-C840D80715A9Q34983966-50A854FE-6E6B-4C7D-BAA0-C7F8E9523070Q35087639-2E6E463B-05F1-480E-AEBF-6DEE19490845Q35672293-C3987FE3-8413-4AD4-B396-94DE05BA9321Q36119183-D64FB771-45C0-4B3F-9111-288288D9C650Q36136307-89D88F29-86D2-4A9F-8907-9F23920D25D1Q36341443-92A9A8CD-756D-4AA0-9CCD-A7792D6BACC3Q36365747-13EB6DC6-15B6-4E2E-B37C-3BE40B9CA734Q37196999-1676D66C-2D29-4945-A787-D8CB958F83E9Q37212371-C31A051B-9902-414B-8361-9159C3F0AE87Q38696906-BBE50354-3B54-4065-9A1E-80F3EEA8387FQ38752822-ABDC0CD1-D077-458D-9233-0F7E8911A7FBQ38906083-541E91A8-5E0F-4A15-B462-FD5F96A11A2FQ38916209-B93F5198-E0F5-4B40-830D-A656AE3A6BA2Q38947511-2C6A6F44-6E27-4343-8CFB-05C29F55EBD4Q39194457-B4C99B7B-555F-4E29-89DD-ED9B81DBCC4CQ40142063-0152B61D-8D77-45CD-B69D-709FB5024F85Q41048773-D971F511-A9CA-462A-8338-F85646590058Q41610540-13E59CA4-B709-4188-9AA7-F12B22D46A76Q41685295-65068731-B257-4745-A683-F33E74B38D34Q42126275-20A803D1-33CC-4013-A952-3F61F640AE96Q43185759-DFB9351D-0476-4CE1-8C24-87F507053D91Q45033916-A009012C-593D-4CAA-BEA1-4DF05A8D1FA7Q47099145-5990775A-1B0C-48AF-A56D-53E649793B67Q47219014-E4730A08-69C1-43F6-B4C0-FE93A7EE0D98Q47422451-F6441D02-C6D2-4C3B-8B74-C055067DBD71Q55058455-210C8D76-3430-483D-A404-881A5C3560E0Q55429885-019751FA-7071-46B0-8DDF-13D65505DC8AQ55519853-023CA54F-8227-4F2B-B33D-B9C328B4740CQ58765929-3DD621B3-BB70-4C53-83CC-84DAB3AA0564
P2860
Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Establishment and characteriza ...... g diffuse large cell lymphoma.
@en
Establishment and characteriza ...... g diffuse large cell lymphoma.
@nl
type
label
Establishment and characteriza ...... g diffuse large cell lymphoma.
@en
Establishment and characteriza ...... g diffuse large cell lymphoma.
@nl
prefLabel
Establishment and characteriza ...... g diffuse large cell lymphoma.
@en
Establishment and characteriza ...... g diffuse large cell lymphoma.
@nl
P2093
P1433
P1476
Establishment and characteriza ...... ng diffuse large cell lymphoma
@en
P2093
Abigail Guija de Arespacochaga
Barbara C Rütgen
Ilse Schwendenwein
Maria Christian
Michael Willmann
Miriam Kleiter
Sabine E Hammer
P304
P356
10.1016/J.LEUKRES.2010.01.021
P4510
P577
2010-02-11T00:00:00Z